Founded in 2021, the company is a new modern IVD enterprise specializing in the research and development, production and sales of diagnostic reagents. The company is located in Wuhan Optics Valley International Biomedical Enterprise Accelerator Park, with a construction area of 2, 400 square meters, a registered capital of 10 million yuan, rich human resources and strong technical force.

The company designs and constructs clean workshops according to GMP standards, introduces domestic advanced production equipment and inspection instruments, establishes a scientific and perfect quality management system according to GMP and ISO13485 standards, and obtains a medical device production license in 2023. The company continues to deepen the construction of technology platforms, and has established four major technology platforms of fluorescence chromatography, colloidal gold, immunoturbidimetry and chemiluminescence, focusing on products in the field of POCT, covering five major fields: Renal function, cardiovascular, reproductive, digestive metabolism and inflammation.